Delivery Order SPE2DB20D7059-SPE2DB25FGTH7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,484.37 to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials, with an ultimate completion date of August 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency (DLA) awarded a $1,798.12 delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/ml vials, with a completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials on July 23, 2025, with a ceiling value of $2,186.12. This non-competitive delivery order utilizes firm fixed pricing and represents a single pharmaceutical supply transaction to support federal medical procurement needs. The contract is scheduled for completion on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $1,316.47 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 5, 2025, and represents a non-set-aside competitive award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.98 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/mL vials under a firm fixed-price contract. The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a non-set-aside competitive award for this cardiovascular medication. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Hydralazine 20 mg/mL vials under a firm fixed-price arrangement. The contract, with a ceiling value of $1,604.30 and a completion date of September 8, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor...
- The Defense Logistics Agency Troop Support Medical awarded a $225,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20 mg/mL vials of hydralazine. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from June 29, 2023 through June 30, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this delivery order will provide the DLA with approximately $225,000 worth of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydralazine 20 mg/ml vials. The contract has a ceiling value of $1,327.85 and a performance period through June 27, 2025. The contract is not set aside and allows for the delivery of both brand-name and generic pharmaceutical products to support military and government healthcare needs. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Hydralazine 20 mg/mL vials totaling $1,482.82. This competitively awarded, non-set-aside contract was executed on August 28, 2025, with an ultimate completion date of August 29, 2025. The delivery order represents a firm fixed price transaction with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydralazine 20 mg/ml vial, a medication used for the treatment of hypertension. The award, valued at $2,326.77, is a Firm Fixed Price Delivery Order with a completion date of July 3, 2024. The contract has no set-aside designation, indicating open competition....
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGTH7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,545.87 to AmerisourceBergen Drug Corp for the supply of Hydralazine 20 mg/ml vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order is scheduled for completion by September 26, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Hydralazine is a vasodilator medication commonly used in military and veteran healthcare systems for hypertension management and emergency acute hypertensive episodes. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of medications and medical supplies supporting military healthcare programs globally. The company's consistent awards through competitive procurement demonstrate its established capability to fulfill diverse federal pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/25/25 |